SCHEMBL3230356

SCHEMBL3230356

O=C(O)c1cn(Cc2ccc(Br)cc2F)c2ccc(F)cc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.50
MAPT P10636 1/20 0.49
TP53 P04637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
AKR1B1 P15121 2/20 0.45
AKR1B10 O60218 1/20 0.45
THRB P10828 1/20 0.45
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CHRM1 P11229 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
RAB9A P51151 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PIK3CD O00329 1/20 0.43
PIK3R1 P27986 1/20 0.43
PIK3CA P42336 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3230362 0.86 AKR1B1 (0.43) IDO1MAPTTP53RXFP1AKR1B1
SCHEMBL3233862 0.83 AKR1B1 (0.56) IDO1MAPTAKR1B1LMNACHRM1
SCHEMBL15111959 0.82 NPC1 (0.58) IDO1MAPTAKR1B1AKR1B10LMNA
SCHEMBL3235201 0.80 CHRM1 (0.65) MAPTTP53RXFP1AKR1B1LMNA
SCHEMBL3238994 0.79 LMNA (0.51) MAPTTP53RXFP1THRBLMNA
SCHEMBL2486523 0.77 CHRM1 (0.58) AKR1B1CHRM1ALDH1A1HSD17B10
SCHEMBL30390219 0.77 KDM4E (0.68) MAPTTHRBLMNASMN1; SMN2KDM4E
SCHEMBL9027382 0.77 KDM4E (0.68) MAPTTHRBLMNASMN1; SMN2KDM4E
SCHEMBL17338594 0.76 LMNA (0.71) LMNACHRM1ALDH1A1
SCHEMBL7056189 0.76 LMNA (0.56) MAPTTP53RXFP1THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963271-B1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME (US) 2010-07-28 EP claimed
CN-101321733-A Quinolone M1 receptor positive allosteric modulators MERCK SHARP & DOHME (US) 2008-12-10 CN claimed
EP-1963271-A1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS Merck & Co., Inc. (US) 2008-09-03 EP claimed
WO-2007067489-A1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK & CO., INC. (US) 2007-06-14 WO claimed
US-8389545-B2 Quinolone M1 receptor positive allosteric modulators Merck, Sharp & Dohme, Corp. (US) 2013-03-05 US disclosed
US-8389545-B2 Quinolone M1 receptor positive allosteric modulators Merck, Sharp & Dohme, Corp. (US) 2013-03-05 US disclosed
US-8389545-B2 Quinolone M1 receptor positive allosteric modulators Merck, Sharp & Dohme, Corp. (US) 2013-03-05 US disclosed
EP-1963271-B1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME (US) 2010-07-28 EP disclosed
CN-101321733-A Quinolone M1 receptor positive allosteric modulators MERCK SHARP & DOHME (US) 2008-12-10 CN disclosed
EP-1963271-A1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS Merck & Co., Inc. (US) 2008-09-03 EP disclosed
WO-2007067489-A1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK & CO., INC. (US) 2007-06-14 WO disclosed
WO-2007067489-A1 QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK & CO., INC. (US) 2007-06-14 WO disclosed